[1]
Buraczewska , A., Kardas , J., Młot , B., Solarek , W. and Waśko-Grabowska , A. 2017. Hypothyroidism caused by cabozantinib therapy of clear cell renal cell carcinoma – case report, own experience. OncoReview. 7, 3(27) (May 2017), 121-125. DOI:https://doi.org/10.24292/01.OR.300517.